|
RPN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.876500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.780580E-01 |
| Normal-vs-Stage2 |
3.333600E-01 |
| Normal-vs-Stage3 |
3.710000E-02 |
| Normal-vs-Stage4 |
7.446400E-01 |
| Stage1-vs-Stage2 |
7.142800E-01 |
| Stage1-vs-Stage3 |
9.407800E-02 |
| Stage1-vs-Stage4 |
5.140800E-01 |
| Stage2-vs-Stage3 |
4.183200E-01 |
| Stage2-vs-Stage4 |
3.921400E-01 |
| Stage3-vs-Stage4 |
1.511590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.237700E-03 |
| Normal-vs-AfricanAmerican |
9.586300E-02 |
| Normal-vs-Asian |
9.471200E-01 |
| Caucasian-vs-AfricanAmerican |
7.017000E-01 |
| Caucasian-vs-Asian |
5.655400E-01 |
| AfricanAmerican-vs-Asian |
6.199800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.719600E-02 |
| Normal-vs-Female |
5.187700E-04 |
| Male-vs-Female |
1.697960E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.043200E-01 |
| Normal-vs-Extreme_Weight |
1.309960E-01 |
| Normal-vs-Obese |
1.202400E-01 |
| Normal-vs-Extreme_Obese |
9.346600E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.474000E-01 |
| Normal_Weight-vs-Obese |
8.756200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.088200E-01 |
| Extreme_Weight-vs-Obese |
9.713200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.136000E-01 |
| Obese-vs-Extreme_Obese |
6.875000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.551900E-02 |
| Normal-vs-Age(41-60Yrs) |
7.897300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.222400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.263400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.923400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.047200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.352800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.888640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.424600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.916000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.042600E-04 |
| Normal-VS-Type2 PRCC |
9.521200E-01 |
| Normal-VS-KIRP CIMP |
1.675250E-01 |
| Normal-VS-Unclassified PRCC |
5.384000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.077790E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.909000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.211200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.116100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.349600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.446200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.734400E-01 |
| Normal-vs-N1 |
1.345000E-01 |
| Normal-vs-N2 |
6.102000E-01 |
| N0-vs-N1 |
2.948800E-01 |
| N0-vs-N2 |
6.909600E-01 |
| N1-vs-N2 |
7.938600E-01 |
|
|
